PSMA imaging agents
US10894807B2 · kind B2 · utility
0Cited by
0References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2018 |
| Grant date | Jan 19, 2021 |
| Priority date | — |
| Expiry date | May 9, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.